This document presents the guidelines for testing antibodies against neuronal surface antigens that have been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of the sponsoring Italian Association of Neuroimmunology (AINI) congresses. Essential clinical information on autoimmune encephalitis associated with antibodies against neuronal surface antigens, indications and limits of testing for such antibodies, instructions for result interpretation, and an agreed laboratory protocol (Appendix A) are reported for the communicative community of neurologists and clinical pathologists.

Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens / L. Zuliani, M. Zoccarato, M. Gastaldi, R. Iorio, A. Evoli, T. Biagioli, S. Casagrande, E. Bazzigaluppi, R. Fazio, C. Giannotta, E. Nobile-Orazio, F. Andreetta, O. Simoncini, G. Costa, S. Mariotto, S. Ferrari, E. Galloni, M. Marcon, D. Franciotta, B. Giometto. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - 38:Suppl. 2(2017), pp. 225-229.

Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens

C. Giannotta;E. Nobile-Orazio
Investigation
;
2017

Abstract

This document presents the guidelines for testing antibodies against neuronal surface antigens that have been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of the sponsoring Italian Association of Neuroimmunology (AINI) congresses. Essential clinical information on autoimmune encephalitis associated with antibodies against neuronal surface antigens, indications and limits of testing for such antibodies, instructions for result interpretation, and an agreed laboratory protocol (Appendix A) are reported for the communicative community of neurologists and clinical pathologists.
Anti-contactin-associated protein-like 2 (CASPR2) antibodies; Anti-leucine-rich glioma inactivated 1 (LGI1) antibodies; Anti-N-methyl-d-aspartate receptor (NMDA-R) antibodies; Cell-based assays; Laboratory diagnostics; 2708; Neurology (clinical); Psychiatry and Mental Health
Settore MED/26 - Neurologia
2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
10.1007%2Fs10072-017-3032-4.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 420.45 kB
Formato Adobe PDF
420.45 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/555517
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 16
social impact